Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?
Caldwell GW, Masucci JA, Yan Z, Hageman W. Caldwell GW, et al. Among authors: masucci ja. Eur J Drug Metab Pharmacokinet. 2004 Apr-Jun;29(2):133-43. doi: 10.1007/BF03190588. Eur J Drug Metab Pharmacokinet. 2004. PMID: 15230342
Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
Wu WN, Masucci JA, Caldwell GW, Carson JR. Wu WN, et al. Among authors: masucci ja. Drug Metab Dispos. 1998 Feb;26(2):115-25. Drug Metab Dispos. 1998. PMID: 9456297
Using capillary electrophoresis/frontal analysis to screen drugs interacting with human serum proteins.
McDonnell PA, Caldwell GW, Masucci JA. McDonnell PA, et al. Among authors: masucci ja. Electrophoresis. 1998 Mar;19(3):448-54. doi: 10.1002/elps.1150190315. Electrophoresis. 1998. PMID: 9551800
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Caldwell GW, Masucci JA, Evangelisto M, White R. Caldwell GW, et al. Among authors: masucci ja. J Chromatogr A. 1998 Mar 27;800(2):161-9. doi: 10.1016/s0021-9673(97)01143-6. J Chromatogr A. 1998. PMID: 9561760
High throughput liquid chromatography-mass spectrometry assessment of the metabolic activity of commercially available hepatocytes from 96-well plates.
Caldwell GW, Masucci JA, Chacon E. Caldwell GW, et al. Among authors: masucci ja. Comb Chem High Throughput Screen. 1999 Feb;2(1):39-51. Comb Chem High Throughput Screen. 1999. PMID: 10420975
Evaluation of the absorption, excretion, and metabolism of the antihypertensive agent RWJ-26899 in male and female CR Wistar rats and Beagle dogs.
Wu WN, Caldwell GW, Masucci JA. Wu WN, et al. Among authors: masucci ja. Eur J Drug Metab Pharmacokinet. 2001 Jul-Sep;26(3):155-66. doi: 10.1007/BF03190391. Eur J Drug Metab Pharmacokinet. 2001. PMID: 11695715
Evaluation of the excretion, and metabolism of the cardiotonic agent bemoradan in male rats and female beagle dogs.
Wu WN, Caldwell GW, Masucci JA, Gauthier AD. Wu WN, et al. Among authors: masucci ja. Eur J Drug Metab Pharmacokinet. 2001 Oct-Dec;26(4):263-71. doi: 10.1007/BF03226381. Eur J Drug Metab Pharmacokinet. 2001. PMID: 11808869
The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery.
Caldwell GW, Ritchie DM, Masucci JA, Hageman W, Yan Z. Caldwell GW, et al. Among authors: masucci ja. Curr Top Med Chem. 2001 Nov;1(5):353-66. doi: 10.2174/1568026013394949. Curr Top Med Chem. 2001. PMID: 11899102 Review.
Evaluation of the excretion and metabolism of the new analgesic agent RWJ-22757 in male and female CR Wistar rats.
Wu WN, Caldwell GW, Masucci JA. Wu WN, et al. Among authors: masucci ja. J Pharm Biomed Anal. 2002 May 15;28(3-4):659-71. doi: 10.1016/s0731-7085(01)00704-x. J Pharm Biomed Anal. 2002. PMID: 12008146
Rapidly distinguishing reversible and irreversible CYP450 inhibitors by using fluorometric kinetic analyses.
Yan Z, Rafferty B, Caldwell GW, Masucci JA. Yan Z, et al. Among authors: masucci ja. Eur J Drug Metab Pharmacokinet. 2002 Oct-Dec;27(4):281-7. doi: 10.1007/BF03192339. Eur J Drug Metab Pharmacokinet. 2002. PMID: 12587958
37 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback